IKNA
Ikena Oncology Inc
$1.61
Earnings Summary
Revenue | $1.19Mn |
Net Profits | $-17.34Mn |
Net Profit Margins | -1463.54% |
Highlights
Ikena Oncology Inc’s revenue fell -81.49% since last year same period to $1.19Mn in the Q3 2023. On a quarterly growth basis, Ikena Oncology Inc has generated -40.87% fall in its revenue since last 3-months.
Ikena Oncology Inc’s net profit fell -3.23% since last year same period to $-17.34Mn in the Q3 2023. On a quarterly growth basis, Ikena Oncology Inc has generated -1.33% fall in its net profits since last 3-months.
Ikena Oncology Inc’s net profit margin fell -457.71% since last year same period to -1463.54% in the Q3 2023. On a quarterly growth basis, Ikena Oncology Inc has generated -71.37% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Ikena Oncology Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.43 |
EPS Estimate Current Year | -0.43 |
Highlights
Ikena Oncology Inc’s earning per share (EPS) estimates for the current quarter stand at -0.43 - a 0% jump from last quarter’s estimates.
Ikena Oncology Inc’s earning per share (EPS) estimates for the current year stand at -0.43.
Key Ratios
Key ratios of the Ikena Oncology Inc post its Q3 2023 earnings
Earning Per Share (EPS) | -0.4 |
Highlights
Ikena Oncology Inc’s earning per share (EPS) jumped 16.67% since last year same period to -0.4 in the Q3 2023. This indicates that the Ikena Oncology Inc has generated 16.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-10 | -0.47 | -0.44 | 6.38% |
2023-11-09 | -0.43 | -0.4 | 6.98% |
2023-05-15 | -0.47 | -0.39 | 17.02% |
₹0 US Stocks a/c Opening Fee